AGM/EGMMay 8, 2026, 04:19 PM
Integra LifeSciences Stockholders Approve 3.55M Share Increase for Equity Plan
AI Summary
Integra LifeSciences Holdings Corporation held its 2026 Annual Meeting of Stockholders on May 7, 2026. Stockholders approved Amendment No. 3 to the 2003 Equity Incentive Plan, increasing the number of shares available for awards by 3,550,000. Additionally, all director nominees were elected, PricewaterhouseCoopers LLP was ratified as the independent auditor, and the compensation of named executive officers was approved on an advisory basis.
Key Highlights
- Stockholders approved Amendment No. 3 to the 2003 Equity Incentive Plan, increasing shares by 3,550,000.
- The Plan Amendment was approved with 68,005,433 "For" votes.
- All seven director nominees were elected to the Board of Directors.
- PricewaterhouseCoopers LLP was ratified as the independent auditor with 72,313,820 "For" votes.
- Executive compensation was approved on an advisory basis with 68,472,769 "For" votes.
Price Impact
More from IART